Departments: Klinik für Gastroenterologie, Hepatologie und Endokrinologie

Centers: Medizinische Hochschule Hannover: Klinik für Gastroenterologie, Hepatologie und Endokrinologie

Discipline

Gastroenterologie und Hepatologie

Leitung

Prof. Dr. M. Manns Germany

Studies

ID	Name	Disease	Status
1199.37	BIBF 1120 vs. Sorafenib for advanced hepatocellular carcinoma	hepatocellular carcinoma	active
MHH_CCA_AG54	Panitumumab + cisplatin/gemcitabine in patients with cholangiocarcinomas (PiCCA)	Cholangiokarzinom	active
ML22011	Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC	colorectal cancer	active
AIO-0209	FOLFOX+Bevacizumab +/- Irinotecan in colorectal cancer (CHARTA)	colorectal cancer	active
AIO-STO-0510	Pazopanib+5-FU+Leukovorin+Oxaliplatin bei Magenkarzinom	gastric cancer	active
AIO-STO-0310	Perioperative treatment of adenocarcinoma of the gastroesophageal junction / stomach (HerFLOT)	gastric cancer	active
PARLIM	Panitumumab after resection of liver metastases from colorectal cancer	colorectal cancer	active
AIO-STO-0309	POWER	esophageal cancer	active
AIO-STO-0110	Catumaxomab for treatment of peritoneal carcinomatosis in patients with gastric adenocarcinomas	gastric cancer	active
CRAD001RDE35T	Paclitaxel +/- RAD001 in patients with gastric carcinoma after prior chemotherapy	gastric cancer	active
15967	Regorafenib in progressed CRC after standard therapy	colorectal cancer	active
CP12-0919	Ramucirumab drug product + BSC vs. placebo + BSC as second-line treatment	hepatocellular carcinoma	active
ML18147		colorectal cancer	closed
CRAD001C24100		hepatocellular carcinoma	closed
EFC10668		colorectal cancer	closed

previous 1 2 3 next